OTHER · Unmapped registry intervention
Comprehensive Geriatric Assessment
Find medicine records ·
Find other trials using this name
Clinical trial
Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer
NCT02673398
Study summary
ClinicalTrials.govNeratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
Laboratory Biomarker Analysis
Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Neratinib
Normalized identity: neratinib View linked drug · Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
Pharmacological Study
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Advertisement
Conditions
Interventions
NeratinibDRUG · verified · RxNorm: neratinib
Sponsors & collaborators
City of Hope Medical Centerlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02673398 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.